shutterstock_1867381765_crocothery
CROCOTHERY / Shutterstock.com
4 March 2021Big PharmaAlex Baldwin

CPI receives £5m from UK govt for 'vaccine library'

UK innovation hub CPI has received a further £5 million ($7 million) investment from the UK government to support the development of new mRNA vaccines to protect against new variants of COVID-19.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
3 August 2020   The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
18 June 2020   The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.
Big Pharma
25 May 2021   Several pharmaceutical organisations have joint-published a five-step plan to help provide more equitable access to COVID-19 vaccines that would avoid waiving IP rights.

More on this story

Americas
3 August 2020   The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
18 June 2020   The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.
Big Pharma
25 May 2021   Several pharmaceutical organisations have joint-published a five-step plan to help provide more equitable access to COVID-19 vaccines that would avoid waiving IP rights.

More on this story

Americas
3 August 2020   The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
18 June 2020   The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.
Big Pharma
25 May 2021   Several pharmaceutical organisations have joint-published a five-step plan to help provide more equitable access to COVID-19 vaccines that would avoid waiving IP rights.